BlackRock’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

BlackRock’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-41,513	Closed	-$66.4K	–	5723
2023 Q1	$66.4K	Hold	41,513	–	–	﹤0.01%	5060
2022 Q4	$82.6K	Hold	41,513	–	–	﹤0.01%	5100
2022 Q3	$144K	Hold	41,513	–	–	﹤0.01%	5067
2022 Q2	$141K	Sell	41,513 -10,574	-20%	-$58.3K	﹤0.01%	5130
2022 Q1	$476K	Buy	52,087 +1,652	+3%	+$25.1K	﹤0.01%	4882
2021 Q4	$1.08M	Sell	50,435 -338	-0.7%	-$9.04K	﹤0.01%	4639
2021 Q3	$1.66M	Buy	50,773 +208	+0.4%	+$7.62K	﹤0.01%	4394
2021 Q2	$2.11M	Sell	50,565 -166,226	-77%	-$8.51M	﹤0.01%	4247
2021 Q1	$14.2M	Buy	216,791 +52,765	+32%	+$3.68M	﹤0.01%	3375
2020 Q4	$10.8M	Buy	164,026 +4,251	+3%	+$277K	﹤0.01%	3318
2020 Q3	$8.68M	Buy	159,775 +1,471	+0.9%	+$113K	﹤0.01%	3303
2020 Q2	$15.1M	Buy	158,304 +5,537	+4%	+$412K	﹤0.01%	2952
2020 Q1	$7.84M	Sell	152,767 -27,778	-15%	-$2.9M	﹤0.01%	3121
2019 Q4	$14.8M	Sell	180,545 -1,935	-1%	-$136K	﹤0.01%	3048
2019 Q3	$15.6M	Buy	182,480 +4,047	+2%	+$432K	﹤0.01%	2960
2019 Q2	$22.8M	Buy	178,433 +9,062	+5%	+$1.31M	﹤0.01%	2779
2019 Q1	$30.5M	Buy	169,371 +2,455	+1%	+$355K	﹤0.01%	2550
2018 Q4	$18.5M	Buy	166,916 +1,675	+1%	+$218K	﹤0.01%	2757
2018 Q3	$22.3M	Buy	165,241 +325	+0.2%	+$44.8K	﹤0.01%	2811
2018 Q2	$22.8M	Buy	164,916 +8,922	+6%	+$1.23M	﹤0.01%	2782
2018 Q1	$21.5M	Sell	155,994 -7,818	-5%	-$1.06M	﹤0.01%	2728
2017 Q4	$20.1M	Sell	163,812 -3,386	-2%	-$465K	﹤0.01%	2780
2017 Q3	$22.8M	Buy	167,198 +1,125	+0.7%	+$170K	﹤0.01%	2734
2017 Q2	$29.1M	Sell	166,073 -5,511	-3%	-$784K	﹤0.01%	2569
2017 Q1	$20.6M	Buy	171,584 +170,949	+26,921%	+$17.8M	﹤0.01%	2744
2016 Q4	$62K	Sell	635 -158	-20%	-$14.5K	﹤0.01%	2833
2016 Q3	$74K	Buy	793 +287	+57%	+$28.8K	﹤0.01%	2770
2016 Q2	$54K	Buy	506 +386	+322%	+$45.2K	﹤0.01%	2901
2016 Q1	$15K	Buy	120 +74	+161%	+$7.77K	﹤0.01%	2990
2015 Q4	$6K	Hold	46	–	–	﹤0.01%	3106
2015 Q3	$8K	Hold	46	–	–	﹤0.01%	2851
2015 Q2	$9K	Sell	46 -9	-16%	-$1.67K	﹤0.01%	2887
2015 Q1	$8K	Hold	55	–	–	﹤0.01%	2867
2014 Q4	$9K	Hold	55	–	–	﹤0.01%	2841
2014 Q3	$8K	Hold	55	–	–	﹤0.01%	2881
2014 Q2	$7K	Hold	55	–	–	﹤0.01%	3024
2014 Q1	$7K	Hold	55	–	–	﹤0.01%	2954
2013 Q4	$6K	Hold	55	–	–	﹤0.01%	3006
2013 Q3	$6K	Hold	55	–	–	﹤0.01%	2947
2013 Q2	$6K	Buy	+55	New	+$6.73K	﹤0.01%	2979

Other funds holding SRGA

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KOC

Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock's SRGA Position: Q2 2023 in Review

BlackRock sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2023, closing a stake of 41,513 shares — an estimated $66.4K sold.

BlackRock first reported a position in SRGA in Q2 2013 and held it in 40 quarters. The position peaked at $30.5M in Q1 2019. 25 funds tracked by Wall St. Rank hold SRGA as of Q2 2023.

BlackRock reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
BlackRock sold 41,513 Surgalign Holdings, Inc. Common Stock shares in Q2 2023, an estimated $66.4K.
BlackRock first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 40 quarters.
BlackRock's Surgalign Holdings, Inc. Common Stock position peaked at $30.5M in Q1 2019.
25 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2023.

Based on BlackRock's 13F filing for Q2 2023, filed 11 Aug 2023.